Estrogen Receptor Modulators and Down Regulators: Optimal Use in Postmenopausal Women With Breast Cancer

Author： Baumann Christa K. Castiglione-Gertsch Monica

ISSN： 0012-6667

Source： Drugs, Vol.67, Iss.16, 2007-01, pp. : 2335-2353

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Selective Estrogen Receptor Modulators and Aromatase Inhibitors for Breast Cancer Chemoprevention

Current Drug Targets, Vol. 12, Iss. 13, 2011-12 ,pp. : 1874-1887

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in Selective Estrogen Receptor Modulators for Breast Cancer

Mini Reviews in Medicinal Chemistry, Vol. 9, Iss. 10, 2009-09 ,pp. : 1191-1201

Bentham Science Publishers

Access to resources Recommend Favorite

The First Organometallic Selective Estrogen Receptor Modulators (SERMs) and Their Relevance to Breast Cancer

Current Medicinal Chemistry, Vol. 11, Iss. 18, 2004-09 ,pp. : 2505-2517

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging Selective Estrogen Receptor Modulators: Special Focus on Effects on Coronary Heart Disease in Postmenopausal Women

By Vogelvang Tatjana Elène Marius Jan van der Mooren Mijatovic Velja Kenemans Peter

Drugs, Vol. 66, Iss. 2, 2006-01 ,pp. : 191-221

Adis International

Access to resources Recommend Favorite

Fulvestrant: A Review of its Use in the Management of Hormone Receptor-Positive Metastatic Breast Cancer in Postmenopausal Women

By Croxtall Jamie D. McKeage Kate

Drugs, Vol. 71, Iss. 3, 2011-02 ,pp. : 363-380

Adis International

Access to resources Recommend Favorite